Thrombolysis for acute ischaemic stroke: current status and future perspectives

G Tsivgoulis, AH Katsanos, EC Sandset, G Turc… - The Lancet …, 2023 - thelancet.com
Alteplase is currently the only approved thrombolytic agent for treatment of acute ischaemic
stroke, but interest is burgeoning in the development of new thrombolytic agents for systemic …

Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial

U Fischer, J Kaesmacher, D Strbian, O Eker… - The Lancet, 2022 - thelancet.com
Background Whether thrombectomy alone is equally as effective as intravenous alteplase
plus thrombectomy remains controversial. We aimed to determine whether thrombectomy …

Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised …

CB Majoie, F Cavalcante, J Gralla, P Yang… - The lancet, 2023 - thelancet.com
Background Intravenous thrombolysis is recommended before endovascular treatment, but
its value has been questioned in patients who are admitted directly to centres capable of …

Tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis of randomized and non-randomized studies

Y Ma, H **ang, JW Busse, M Yao, J Guo, L Ge, B Li… - Journal of …, 2024 - Springer
Objective Alteplase is the current standard of care for acute ischemic stroke. Tenecteplase is
a newer fibrinolytic agent with preferable administration and lower costs; however, its …

Time to treatment with intravenous thrombolysis before thrombectomy and functional outcomes in acute ischemic stroke: a meta-analysis

J Kaesmacher, F Cavalcante, M Kappelhof… - Jama, 2024 - jamanetwork.com
Importance The benefit of intravenous thrombolysis (IVT) for acute ischemic stroke declines
with longer time from symptom onset, but it is not known whether a similar time dependency …

Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial

MB Roaldsen, A Eltoft, T Wilsgaard… - The Lancet …, 2023 - thelancet.com
Background Current evidence supports the use of intravenous thrombolysis with alteplase in
patients with wake-up stroke selected with MRI or perfusion imaging and is recommended in …

Assessment of thrombectomy versus combined thrombolysis and thrombectomy in patients with acute ischemic stroke and medium vessel occlusion

AA Dmytriw, S Ghozy, HA Salim, B Musmar, JE Siegler… - Radiology, 2024 - pubs.rsna.org
Background The combination of intravenous thrombolysis (IVT) with mechanical
thrombectomy (MT) may have clinical benefits for patients with medium vessel occlusion …

Shorter door-to-needle times are associated with better outcomes after intravenous thrombolytic therapy and endovascular thrombectomy for acute ischemic stroke

S Man, N Solomon, B Mac Grory, B Alhanti, K Uchino… - Circulation, 2023 - ahajournals.org
Background: Existing data and clinical trials could not determine whether faster intravenous
thrombolytic therapy (IVT) translates into better long-term functional outcomes after acute …

Advances in mechanical thrombectomy for acute ischaemic stroke

O Raha, C Hall, A Malik, L D'Anna, K Lobotesis… - BMJ …, 2023 - pmc.ncbi.nlm.nih.gov
Mechanical thrombectomy is a ground breaking treatment for acute ischaemic stroke caused
by occlusion of a large vessel. Its efficacy over intravenous thrombolysis has been proven in …

Endovascular thrombectomy for anterior circulation large vessel occlusion stroke: an evolution of trials

N Starikova, S Räty, D Strbian, DPO Kaiser… - Seminars in …, 2023 - thieme-connect.com
The last decade's progress in demonstrating the clinical benefit of endovascular
thrombectomy (EVT) in patients with large vessel occlusion stroke has transformed the …